Table 1. Patient demographics and... | American Society of Hematology

Table 1.

Patient demographics and treatment information for treated DLBCL patients

Patient	Sex	Age, y	Total cycles of chemotherapy	WBC, × 10⁹/L	ALC, × 10⁹/L	Absolute CD3, per μL	Absolute CD4, per μL	Absolute CD8, per μL	Absolute CD19, per μL	Absolute CD56, per μL	Absolute CD16, per μL
1	M	33	12	6.1	1.281	343	99	233	0	206	214
2	M	61	19	11.6	1.856	1013	440	512	156	219	256
3	M	64	7	6.5	.455	259	110	149	0	89	92
4	F	52	5	5.4	1.728	1030	366	355	326	124	214
5	F	64	11	3.4	1.650	1576	423	1091	0	40	55
6	F	33	21	2.7	.648	706	70	636	0	94	118
7	M	41	12	3.1	.690	202	112	87	0	147	133
8	F	38	12	5	1.100	792	261	496	0	176	211
9	M	36	10	5.4	2.240	405	257	139	N/A	N/A	N/A
10	F	47	6	5.8	0.600	430	246	139	N/A	N/A	N/A
11	F	63	6	5.8	1.140	829	342	464	N/A	N/A	N/A
12	M	56	15	2.5	0.540	198	93	94	N/A	N/A	N/A
13*	M	55	6	5.6	0.980	851	719	87	N/A	N/A	N/A
14*	F	52	4	5.9	1.050	915	573	197	N/A	N/A	N/A
15*	M	71	6	3.9	0.772	585	472	99	N/A	N/A	N/A
		46.5	10	5.4	1.050	706	261	197	0	124	133

Patient	Sex	Age, y	Total cycles of chemotherapy	WBC, × 10⁹/L	ALC, × 10⁹/L	Absolute CD3, per μL	Absolute CD4, per μL	Absolute CD8, per μL	Absolute CD19, per μL	Absolute CD56, per μL	Absolute CD16, per μL
1	M	33	12	6.1	1.281	343	99	233	0	206	214
2	M	61	19	11.6	1.856	1013	440	512	156	219	256
3	M	64	7	6.5	.455	259	110	149	0	89	92
4	F	52	5	5.4	1.728	1030	366	355	326	124	214
5	F	64	11	3.4	1.650	1576	423	1091	0	40	55
6	F	33	21	2.7	.648	706	70	636	0	94	118
7	M	41	12	3.1	.690	202	112	87	0	147	133
8	F	38	12	5	1.100	792	261	496	0	176	211
9	M	36	10	5.4	2.240	405	257	139	N/A	N/A	N/A
10	F	47	6	5.8	0.600	430	246	139	N/A	N/A	N/A
11	F	63	6	5.8	1.140	829	342	464	N/A	N/A	N/A
12	M	56	15	2.5	0.540	198	93	94	N/A	N/A	N/A
13*	M	55	6	5.6	0.980	851	719	87	N/A	N/A	N/A
14*	F	52	4	5.9	1.050	915	573	197	N/A	N/A	N/A
15*	M	71	6	3.9	0.772	585	472	99	N/A	N/A	N/A
		46.5	10	5.4	1.050	706	261	197	0	124	133

The bottom row shows median values. All procedures were approved by the Institutional Review Board of Emory University (approval IRB0716).

Paired samples pre- and posttreatment.

ALC, absolute lymphocyte count; F, female; M, male; N/A, not available; WBC, white blood cell count.